Kamal Khademvatani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kamal Khademvatani has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Yousef Rezaei
Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
7 shared publications Alireza Rostamzadeh
Seyyed-al Shohada University Hospital, Urmia University of Medical Sciences, Urmia, Iran
6 shared publications- Mir Hosein Seyyed Mohammadzad
Department of Cardiology, Urmia University of Medical Sciences, Urmia, Iran
5 shared publications Mir Hossein Seyyed-Mohammadzad
Department of Cardiology, Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences; Urmia-Iran.
4 shared publicationsRamin Eskandari
Department of Cardiology, Firoozgar Hospital, Iran University of Medial Sciences, Tehran, Iran
4 shared publicationsAbdollah Kerachian
Department of Cardiology, Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences, Urmia, Iran
2 shared publications
Latest Publications
- Open Access
- 1 September 2025
- Published by National Academy of Sciences of Tajikistan in Journal of Health Administration
- Vol. 28 (2) , 53-69
Predicting the length of hospital stay in patients with congestive heart failure using data mining techniques
Introduction: Congestive heart failure (CHF) is a significant global challenge for healthcare systems, with its prevalence increasing due to an aging population. Accurate prediction of the length of stay (LOS) for CHF patients is critical for optimizing hospital resource management, reducing treatment costs, and improving the quality of medical care. This ...
- 1 September 2025
- Published by National Academy of Sciences of Tajikistan in Journal of Health Administration
- Vol. 28 (2) , 53-69
Open AccessPredicting the length of hospital stay in patients with congestive heart failure using data mining techniques
Introduction: Congestive heart failure (CHF) is a significant global challenge for healthcare systems, with its prevalence increasing due to an aging population. Accurate prediction of the length of stay (LOS) for CHF patients is critical for optimizing hospital resource management, reducing treatment costs, and improving the quality of medical care. This ...
- Open Access
- 1 October 2024
- Published by Apex Publishing in Nursing and Midwifery Journal
- Vol. 22 (7) , 592-606
FROM TREATMENT TO MENTAL HEALTH: INVESTIGATING THE RELATIONSHIP BETWEEN THERAPEUTIC APPROACHES IN MYOCARDIAL INFARCTION AND POST-MI DEPRESSION AND ANXIETY – A DESCRIPTIVE-CORRELATIONAL STUDY
Background & Aim: Myocardial infarction is one of the most common cardiovascular diseases, typically caused by thrombotic obstruction. The severity of myocardial damage and its outcomes can vary depending on the location and extent of coronary artery involvement. Consequently, this variability can lead to differing levels of depression and anxiety ...
- 1 October 2024
- Published by Apex Publishing in Nursing and Midwifery Journal
- Vol. 22 (7) , 592-606
Open AccessFROM TREATMENT TO MENTAL HEALTH: INVESTIGATING THE RELATIONSHIP BETWEEN THERAPEUTIC APPROACHES IN MYOCARDIAL INFARCTION AND POST-MI DEPRESSION AND ANXIETY – A DESCRIPTIVE-CORRELATIONAL STUDY
Background & Aim: Myocardial infarction is one of the most common cardiovascular diseases, typically caused by thrombotic obstruction. The severity of myocardial damage and its outcomes can vary depending on the location and extent of coronary artery involvement. Consequently, this variability can lead to differing levels of depression and anxiety ...
- Open Access
- 1 December 2023
- Published by Apex Publishing in Nursing and Midwifery Journal
- Vol. 21 (9) , 718-729
COMPARISON OF THE EFFECTIVENESS OF ACUPRESSURE AND BENSON’S RELAXATION ON THE LEVEL OF ANXIETY IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
Background & Aim: Cardiovascular diseases are considered one of the most common causes of death worldwide. Given the increasing trend of heart diseases, one of the most common diagnostic and therapeutic methods that aid in the diagnosis and treatment of heart diseases is coronary angiography. Patients undergoing coronary angiography report ...
- 1 December 2023
- Published by Apex Publishing in Nursing and Midwifery Journal
- Vol. 21 (9) , 718-729
Open AccessCOMPARISON OF THE EFFECTIVENESS OF ACUPRESSURE AND BENSON’S RELAXATION ON THE LEVEL OF ANXIETY IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
Background & Aim: Cardiovascular diseases are considered one of the most common causes of death worldwide. Given the increasing trend of heart diseases, one of the most common diagnostic and therapeutic methods that aid in the diagnosis and treatment of heart diseases is coronary angiography. Patients undergoing coronary angiography report ...
- Open Access
- 20 July 2020
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
- Vol. 10 (1) , e07
The predictive value of serum klotho in diabetes mellitus and hypertension
Introduction: Klotho allele status is associated with increased risk of cardiovascular diseases, diabetes and hypertension. Objectives: To determine if serum klotho level was lower among diabetic and hypertensive patients compared to control group. Patients and Methods: This was a cross-sectional study of 90 participants. Thirty pure diabetic patients and 30 participants with pure hypertension were compared with the healthy control group. Multiple logistic regressions were used to examine the association between serum klotho and diabetes and hypertension. We also tested the cut off point of serum klotho to predict hypertension and diabetes by using ROC (receiver operating characteristic) curve. Results: The level of serum klotho was significantly lower in diabetic and hypertensive patients. Participants with higher klotho were less likely to have diabetes and hypertension [OR: 0.48, 95% CI (0.22-0.81)] even after adjustment for covariates. ROC curve for diabetes and hypertension indicated 0.8 area under the curve which was statistically significant. Conclusion: This study found that serum klotho was associated with lower odds of diabetes and hypertension. Further longitudinal studies are necessary to confirm this finding.
- 20 July 2020
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
- Vol. 10 (1) , e07
Open AccessThe predictive value of serum klotho in diabetes mellitus and hypertension
Introduction: Klotho allele status is associated with increased risk of cardiovascular diseases, diabetes and hypertension. Objectives: To determine if serum klotho level was lower among diabetic and hypertensive patients compared to control group. Patients and Methods: This was a cross-sectional study of 90 participants. Thirty pure diabetic patients and 30 participants with pure hypertension were compared with the healthy control group. Multiple logistic regressions were used to examine the association between serum klotho and diabetes and hypertension. We also tested the cut off point of serum klotho to predict hypertension and diabetes by using ROC (receiver operating characteristic) curve. Results: The level of serum klotho was significantly lower in diabetic and hypertensive patients. Participants with higher klotho were less likely to have diabetes and hypertension [OR: 0.48, 95% CI (0.22-0.81)] even after adjustment for covariates. ROC curve for diabetes and hypertension indicated 0.8 area under the curve which was statistically significant. Conclusion: This study found that serum klotho was associated with lower odds of diabetes and hypertension. Further longitudinal studies are necessary to confirm this finding.
- Open Access
The Study of Acute Myocardial Infarctions Triggers in North-Western Iran
Background: Myocardial infarction (MI) is one of the important cardiovascular diseases. A trigger is an external stimulus, potential to create a pathological change leading to a clinical event. In addition to the risk factors of myocardial infarction, MI triggers play critical roles in the incidence of acute MI. Methods and Results: This is a cross-sectional study of patients with the first acute myocardial infarction in Seyedoshohada heart center of Urmia, Iran. 254 patients were enrolled in the study within one year of study. After 48 h of hospitalization, the patients were provided with the questionnaire to collecting the history of the disease ad triggers. Out of 220 (86.4%) patients with STEMI and 34 (13.6%) patients with NSTEMI, there were significant differences (p 2 . Conclusion: In addition to classic risk factors of myocardial infarction, health care systems must pay more attention to triggers that may induce an acute myocardial infarction in people with predisposing factors especially in the male sex, stressful and hand working jobs, and psychological and mental tension patients.
Open AccessThe Study of Acute Myocardial Infarctions Triggers in North-Western Iran
Background: Myocardial infarction (MI) is one of the important cardiovascular diseases. A trigger is an external stimulus, potential to create a pathological change leading to a clinical event. In addition to the risk factors of myocardial infarction, MI triggers play critical roles in the incidence of acute MI. Methods and Results: This is a cross-sectional study of patients with the first acute myocardial infarction in Seyedoshohada heart center of Urmia, Iran. 254 patients were enrolled in the study within one year of study. After 48 h of hospitalization, the patients were provided with the questionnaire to collecting the history of the disease ad triggers. Out of 220 (86.4%) patients with STEMI and 34 (13.6%) patients with NSTEMI, there were significant differences (p 2 . Conclusion: In addition to classic risk factors of myocardial infarction, health care systems must pay more attention to triggers that may induce an acute myocardial infarction in people with predisposing factors especially in the male sex, stressful and hand working jobs, and psychological and mental tension patients.
- Open Access
Echocardiographic and Laboratory Findings in Coronary Slow Flow Phenomenon: cross-sectional study and review
Background and aims: Coronary Slow flow is a phenomenon known as slow contrast flow that injected into the coronary arteries, without epicardial coronary arteries obstruction. The etiology of this disease is unknown. Endothelial dysfunction, known as a major cause of Coronary Slow flow syndrome (CSF). Methods: This study was cross-sectional (descriptive-analytic), which was performed on patients admitted to Seyedoshohada Heart Center, during one year (2018-2019). Considering the inclusion and exclusion criteria, patients were divided into two groups of normal coronary arteries (NECA, as the control group) and with the Coronary slow-flow (CSF). Results: In the present study, 124 patients were studied, 67.9% in the coronary slow flow group and 39.4% in the control group were men (p=0.001). In the coronary slow flow group, the mean age of patients was 52.18 ± 12.55 years and in the control group, the mean age was 51.77 ± 10.36 years (p=0.18). Mean BMI was significantly higher in the coronary slow flow group than the control group (p <0.05). The smoking, hypertension, and mean of Lymphocyte, Hb, Hct, Plt, MPV, RDW, BUN, FBS, TG, TC, LDL was significantly higher coronary slow flow group. Also, in echocardiography, the mean E wave, E/A ratio was significantly lower in the coronary slow flow group. The GLS was also significantly lower in the control group (p=0.01). LAD was the most common type of coronaries that involved with a slow flow. Conclusion: The results of this study showed that there was a significant increase in the rate of coronary slow flow in men, smokers, high BMI, and hypertensive patients. Also, platelet count, MPV, LDL, FBS, and some laboratory variables were high in patients with CSF. Mild diastolic dysfunction and low GLS were observed in this group of patients.
Open AccessEchocardiographic and Laboratory Findings in Coronary Slow Flow Phenomenon: cross-sectional study and review
Background and aims: Coronary Slow flow is a phenomenon known as slow contrast flow that injected into the coronary arteries, without epicardial coronary arteries obstruction. The etiology of this disease is unknown. Endothelial dysfunction, known as a major cause of Coronary Slow flow syndrome (CSF). Methods: This study was cross-sectional (descriptive-analytic), which was performed on patients admitted to Seyedoshohada Heart Center, during one year (2018-2019). Considering the inclusion and exclusion criteria, patients were divided into two groups of normal coronary arteries (NECA, as the control group) and with the Coronary slow-flow (CSF). Results: In the present study, 124 patients were studied, 67.9% in the coronary slow flow group and 39.4% in the control group were men (p=0.001). In the coronary slow flow group, the mean age of patients was 52.18 ± 12.55 years and in the control group, the mean age was 51.77 ± 10.36 years (p=0.18). Mean BMI was significantly higher in the coronary slow flow group than the control group (p <0.05). The smoking, hypertension, and mean of Lymphocyte, Hb, Hct, Plt, MPV, RDW, BUN, FBS, TG, TC, LDL was significantly higher coronary slow flow group. Also, in echocardiography, the mean E wave, E/A ratio was significantly lower in the coronary slow flow group. The GLS was also significantly lower in the control group (p=0.01). LAD was the most common type of coronaries that involved with a slow flow. Conclusion: The results of this study showed that there was a significant increase in the rate of coronary slow flow in men, smokers, high BMI, and hypertensive patients. Also, platelet count, MPV, LDL, FBS, and some laboratory variables were high in patients with CSF. Mild diastolic dysfunction and low GLS were observed in this group of patients.
- Open Access
- 17 March 2018
- Published by Maad Rayan Publishing Company in Journal of Cardiovascular and Thoracic Research
- Vol. 10 (1) , 20-23
Analysis of the mutations in exon 10 of MEFV gene in patients with premature coronary heart disease in west Azerbaijan province of Iran
Introduction: Premature coronary heart disease (PCHD) affects public health and leads to death. PCHD has several genetic and environmental risk factors. The aim of this study was to analysis of the mutations in exon 10 of MEFV gene in patients with PCHD in West Azerbaijan province of Iran. Methods: Totally 41 PCHD patients who were admitted to the cardiology unit of Sayedoshohada hospital (Urmia, Iran) enrolled in the study. Selection of the patients was done based on the strict criteria, that is, who had a minimum of one angiographically documented coronary artery with the stenosis of 50%. Mutations in exon 10 of MEFV gene were found by direct sequencing. Results: V726A, M680I, K695R, and A744S mutations with 2.44%, 1.22%, 1.22%, and 1.22%, allelic frequency were found, respectively. Five patients (12.2%) with PCHD carried at least one mutated MEFV allele. Heterozygote V726A was the most frequent mutation among tested cases (4.88%), followed by heterozygote M680I, heterozygote K695R, and heterozygote A744S. Conclusion: The results of the present study imply that the frequency of the MEFV gene exon 10 is significantly high in PCHD patients. This is the first report in its own kind in clinically diagnosed PCHD patients of Iranian Azeri Turkish population.
- 17 March 2018
- Published by Maad Rayan Publishing Company in Journal of Cardiovascular and Thoracic Research
- Vol. 10 (1) , 20-23
Open AccessAnalysis of the mutations in exon 10 of MEFV gene in patients with premature coronary heart disease in west Azerbaijan province of Iran
Introduction: Premature coronary heart disease (PCHD) affects public health and leads to death. PCHD has several genetic and environmental risk factors. The aim of this study was to analysis of the mutations in exon 10 of MEFV gene in patients with PCHD in West Azerbaijan province of Iran. Methods: Totally 41 PCHD patients who were admitted to the cardiology unit of Sayedoshohada hospital (Urmia, Iran) enrolled in the study. Selection of the patients was done based on the strict criteria, that is, who had a minimum of one angiographically documented coronary artery with the stenosis of 50%. Mutations in exon 10 of MEFV gene were found by direct sequencing. Results: V726A, M680I, K695R, and A744S mutations with 2.44%, 1.22%, 1.22%, and 1.22%, allelic frequency were found, respectively. Five patients (12.2%) with PCHD carried at least one mutated MEFV allele. Heterozygote V726A was the most frequent mutation among tested cases (4.88%), followed by heterozygote M680I, heterozygote K695R, and heterozygote A744S. Conclusion: The results of the present study imply that the frequency of the MEFV gene exon 10 is significantly high in PCHD patients. This is the first report in its own kind in clinically diagnosed PCHD patients of Iranian Azeri Turkish population.
- 1 October 2017
- Published by Elsevier in Thrombosis Research
- Vol. 158, 76-78
Study on a novel polymorphism in the VKORC1 promoter region using bioinformatic tools and warfarin dosing data
- 1 October 2017
- Published by Elsevier in Thrombosis Research
- Vol. 158, 76-78
Study on a novel polymorphism in the VKORC1 promoter region using bioinformatic tools and warfarin dosing data
- Open Access
- 9 March 2016
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 5 (3) , e002919
Short‐Term High‐Dose Vitamin E to Prevent Contrast Medium–Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo‐Controlled Trial
Background: Contrast medium–induced acute kidney injury ( CIAKI ) is a leading cause of acquired renal impairment. The effects of antioxidants have been conflicting regarding the prevention of CIAKI . We performed a study of vitamin E use to decrease CIAKI in patients undergoing elective coronary angiography. Methods and Results: In a placebo‐controlled randomized trial at 2 centers in Iran, 300 patients with chronic kidney disease—defined as estimated glomerular filtration rate 2 —were randomized 1:1 to receive 0.9% saline infusion 12 hours prior to and after intervention combined with 600 mg vitamin E 12 hours before plus 400 mg vitamin E 2 hours before coronary angiography or to receive placebo. The primary end point was the development of CIAKI, defined as an increase ≥0.5 mg/dL or ≥25% in serum creatinine that peaked within 72 hours. Based on an intention‐to‐treat analysis, CIAKI developed in 10 (6.7%) and 21 (14.1%) patients in the vitamin E and placebo groups, respectively ( P =0.037). Change in white blood cell count from baseline to peak value was greater in the vitamin E group compared with the placebo group (−500 [−1500 to 200] versus 100 [−900 to 600]×10 3 /mL , P =0.001). In multivariate analysis, vitamin E (odds ratio 0.408, 95% CI 0.170–0.982, P =0.045) and baseline Mehran score (odds ratio 1.257, 95% CI 1.007–1.569; P =0.043) predicted CIAKI. Conclusions: Prophylactic short‐term high‐dose vitamin E combined with 0.9% saline infusion is superior to placebo for prevention of CIAKI in patients undergoing elective coronary angiography. Clinical Trial Registration: URL : https://www.clinicaltrials.gov/ . Unique identifier: NCT 02070679.
- 9 March 2016
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 5 (3) , e002919
Open AccessShort‐Term High‐Dose Vitamin E to Prevent Contrast Medium–Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo‐Controlled Trial
Background: Contrast medium–induced acute kidney injury ( CIAKI ) is a leading cause of acquired renal impairment. The effects of antioxidants have been conflicting regarding the prevention of CIAKI . We performed a study of vitamin E use to decrease CIAKI in patients undergoing elective coronary angiography. Methods and Results: In a placebo‐controlled randomized trial at 2 centers in Iran, 300 patients with chronic kidney disease—defined as estimated glomerular filtration rate 2 —were randomized 1:1 to receive 0.9% saline infusion 12 hours prior to and after intervention combined with 600 mg vitamin E 12 hours before plus 400 mg vitamin E 2 hours before coronary angiography or to receive placebo. The primary end point was the development of CIAKI, defined as an increase ≥0.5 mg/dL or ≥25% in serum creatinine that peaked within 72 hours. Based on an intention‐to‐treat analysis, CIAKI developed in 10 (6.7%) and 21 (14.1%) patients in the vitamin E and placebo groups, respectively ( P =0.037). Change in white blood cell count from baseline to peak value was greater in the vitamin E group compared with the placebo group (−500 [−1500 to 200] versus 100 [−900 to 600]×10 3 /mL , P =0.001). In multivariate analysis, vitamin E (odds ratio 0.408, 95% CI 0.170–0.982, P =0.045) and baseline Mehran score (odds ratio 1.257, 95% CI 1.007–1.569; P =0.043) predicted CIAKI. Conclusions: Prophylactic short‐term high‐dose vitamin E combined with 0.9% saline infusion is superior to placebo for prevention of CIAKI in patients undergoing elective coronary angiography. Clinical Trial Registration: URL : https://www.clinicaltrials.gov/ . Unique identifier: NCT 02070679.
- Open Access
- 7 February 2016
- Published by SAGE Publications in Therapeutic Advances in Cardiovascular Disease
- Vol. 10 (4) , 206-213
Comparing clinical outcomes for a twelve-month trial of zotarolimus- and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registry
New-generation coronary stents including zotarolimus- and everolimus-eluting stents (ZES and EES) have been shown to decrease the risk of restenosis. The purpose of this study was to compare the safety and efficacy of ZES and EES over a 12-month clinical follow up, in routine clinical practice. This is an observational study in which 1029 consecutive patients treated with ZES (n = 669) or EES (n = 360) were enrolled. The study endpoint was major adverse cardiac events (MACE), defined as cardiac death, nonfatal myocardial infarction (MI), and target lesion or vessel revascularization at 12 months. Follow up was completed among 94.9% of the patients. The overall MACE occurred in 4 (0.6%) and 7 (2.0%) patients in the ZES and EES group, respectively. The occurrence of other cardiac events including nonfatal MI and target vessel or lesion revascularization was 1 (0.2%) versus 1 (0.3%) and 7 (1.1%) versus 5 (1.4%), respectively, in the ZES and EES groups of patients. Despite a slightly lower rate of MACE and cardiac death in the ZES group, the difference between these two groups was not significant (n = 0.064 for overall MACE, p = 0.129 for cardiac mortality, n = 0.999 for nonfatal MI, n = 0.468 for target vessel and n = 0.999 for target lesion revascularization). According to our results, it could be concluded that the difference in the rate of MACE between the ZES and EES groups was not statistically significant at 12-month follow up.
- 7 February 2016
- Published by SAGE Publications in Therapeutic Advances in Cardiovascular Disease
- Vol. 10 (4) , 206-213
Open AccessComparing clinical outcomes for a twelve-month trial of zotarolimus- and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registry
New-generation coronary stents including zotarolimus- and everolimus-eluting stents (ZES and EES) have been shown to decrease the risk of restenosis. The purpose of this study was to compare the safety and efficacy of ZES and EES over a 12-month clinical follow up, in routine clinical practice. This is an observational study in which 1029 consecutive patients treated with ZES (n = 669) or EES (n = 360) were enrolled. The study endpoint was major adverse cardiac events (MACE), defined as cardiac death, nonfatal myocardial infarction (MI), and target lesion or vessel revascularization at 12 months. Follow up was completed among 94.9% of the patients. The overall MACE occurred in 4 (0.6%) and 7 (2.0%) patients in the ZES and EES group, respectively. The occurrence of other cardiac events including nonfatal MI and target vessel or lesion revascularization was 1 (0.2%) versus 1 (0.3%) and 7 (1.1%) versus 5 (1.4%), respectively, in the ZES and EES groups of patients. Despite a slightly lower rate of MACE and cardiac death in the ZES group, the difference between these two groups was not significant (n = 0.064 for overall MACE, p = 0.129 for cardiac mortality, n = 0.999 for nonfatal MI, n = 0.468 for target vessel and n = 0.999 for target lesion revascularization). According to our results, it could be concluded that the difference in the rate of MACE between the ZES and EES groups was not statistically significant at 12-month follow up.